Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,591.41
(
0.15%
)
US TECH 100
29,674.80
(
0.48%
)
Dow Jones
50,890.52
(
-0.28%
)
Brent Oil
96.58
(
5.71%
)
Bitcoin
70,980.45
(
-3.50%
)
News Focus
News Focus
Post# of 446737
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Couch

Send PM Follow Ignore
Followers 280
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Couch

Re: Don'tDrinkTheKoolAid post# 249261

Tuesday, 04/04/2017 7:48:58 AM

Tuesday, April 04, 2017 7:48:58 AM

Post# of 446737
Sure thing only the FDA green lighting the SequestOx path to approval says this has little to do with hope at this point. Nasrat has already conducted in house BE studies.

Nasrat already filed generic Percocet and Norco - he isn't having trouble understanding anything.

Intrinsic value about to come in line with the market value in the next 12-18 months.

Elite filed its generic Percocet in August 2016 - May just may be an interesting month for Elite.

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ELTP News
More ELTP News